Physicians are frequently asked by their surgical or anaesthetic colleagues whether a patient is "fit for surgery," and such an opinion is especially likely to be sought if the patient has recently had a myocardial infarction. Among all the factors which are at times alleged to trigger off an infarct-industrial injury, physical exertion, mental stress, excitement, grief-the one which is indisputable is a surgical operation. The as the interval between the preceding infarct and surgery lengthened. Preoperative hypertension, intraoperative hypotension, and abdominal or non-cardiac thoracic procedures lasting over three hours were adverse factors, but not the mere presence of preoperative angina.
Finally, a recent survey from Finland," important because it was a prospective study, delivers one more blow on the same sensitive spot. It covered 12 654 surgical patients, of whom 214 were selected on account of a preoperative myocardial infarction or abnormal electrocardiogram. In the vast majority with no preoperative history of heart disease and a normal electrocardiogram there were 12 postoperative myocardial infarcts (0.1%). Of the selected 214 with previous evidence of coronary disease, 38 patients had infarcts (18%), most of which occurred during the first three postoperative days. Again, the longer the interval between the first infarct and surgery the lower the incidence of reinfarction. A third of the patients had no pain from their infarct, and some two-fifths would have gone undetected had electrocardiographic screening not been performed. Just over a third of the patients who had infarcts died, the mortality being much the same for both transmural and subendocardial lesions. Intraoperative hypotensive episodes were an adverse factor, but not the duration of anaesthesia or again the presence of preoperative angina.
A physician bears a heavy responsibility if his verdict "Not fit for surgery" for ever bars a patient from a procedure such as hip replacement which might improve his quality of life over many years. But the accumulated evidence, not much more encouraging in recent years despite advances in anaesthetic techniques,'0 12 still clearly shows that operations are a potent precipitating cause of infarcts and that the mortality is high. Elective non-lifesaving procedures should therefore be deferred for at least three and probably for six months after a known infarct. More prolonged delay might raise the possibility that in the clinical course of coronary disease renewed instability of the coronary circulation might be expected sooner or later. Surgery should be avoided when possible in patients with angina occurring at rest or on mild exertion, in those in whom angina has suddenly got worse, and in those with signs of cardiac failure. Anticoagulant 
Drugs and sperm
A healthy man's sperm count may vary widely from month to month or even from week to week. The count is influenced by his health in the months preceding spermatogenesis and by events during the maturation of the spermatozoa. A low count may result from stress, disease, or drugs or may have no obvious cause.
Nevertheless, some effects of drugs are known. Hormones can influence the sperm count. Oestrogens,l androgens,2 and some progestogens decrease spermatogenesis by lowering plasma gonadotrophin concentrations. The antioestrogens clomiphene3 and tamoxifen4 have been used to treat idiopathic oligospermia but with varying success. The antiandrogen cyproterone acetate decreases the sperm count5 but seems unsuitable as a contraceptive for men because it affects potency and because the sperm count may increase again after prolonged treatment.2 Other problems with using steroid combinations as a "male pill" include their slow and inconsistent effects on the sperm count and their side effects. 2 Cytotoxic drugs cause oligospermia by directly affecting the germinal epithelium.6 7 Alkylating agents have a dose-related effect and may cause testicular atrophy, but function may regenerate many months after stopping treatment.6 Methotrexate given for psoriasis produces oligospermia,8 though plasma hormone concentrations remain normal: the oligospermia improves within a few months of stopping the drug. There are reports of azoospermia after administration of iodine-1319 and during treatment with colchicine.'0 Various toxic chemicals used in industry and agriculture have also come under suspicion, and the nematocide 1,2-dibromo-3-chloropropane has been identified (after 20 years of use) as a cause of oligospermiall; this may be reversible if exposure is stopped in time.12 Excessive absorption of lead may affect the sperm count.13
These effects are not unexpected, but more surprising is the influence of sulphasalazine. In the 1940s this drug was introduced for the treatment of ulcerative colitis, and in 1979 the first reports of oligospermia appeared (though it had already been suspected by some doctors14). In these early reports six patients'4 in America and four'5 in England had oligospermia, which quickly improved when sulphasalazine was withdrawn-despite a worsening of bowel symptoms in some cases. Two more recent studies have added another 49 cases. In London 18 of the 28 patients16 had gross abnormalities of their semen but no endocrine abnormality: the semen improved two months after stopping sulphasalazine and 10 pregnancies occurred. In Glasgow 18 of the 21 patients'7 had abnormal semen, and 15 had oligospermia. One patient discontinued treatment and had a normal semen analysis result two months later. The mechanism of the side effect is not clear, but it seems that either sulphasalazine or a metabolite is toxic to developing spermatozoa. This raises questions about those men who remain fertile while having treatment. In Glasgow five patients had become fathers while taking sulphasalazine; one baby was stillborn but the others were normal.
Reports on other drugs are few, and controlled trialsl8 are very few indeed. Psychotropic drugs,' especially monoamine oxidase inhibitors,19 are thought to affect the sperm count adversely, but amitriptyline seems to improve oligospermia in some men20: it is difficult to tell whether such effects are those of the drug or of the disease. There are unconfirmed reports of adverse effects from amoebicides,'9 antimalarials,19 nitrofurantoin,1'9 reserpine,l and co-trimoxazole.2' This last observation may be merely the effect of normal variation,22 and indeed co-trimoxazole is used to treat infertility related to chronic prostatitis.2' Cigarette smoking has been reported to increase the numbers of abnormal spermatozoa.2' The search continues for an agent which will lower the sperm count without other effects, and in the Far East hope is now centred on gossypol acetic acid,2' now being tested in China and India. Of more immediate concern, however, is the possibility-emphasised by the reports on sulphasalazine-that familiar drugs may have this side effect without it being recognised.
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